← All courses at University of St Andrews

MChem Chemistry with Medicinal Chemistry

University of St Andrews

Institution
University of St Andrews
Level
undergraduate
Subject
Chemistry with Medicinal Chemistry
Duration
5 years
UCAS code
F152 (with external placement: F151)
Typical offer
A-level AAA

Entry requirements

A level: AAA, including A in Chemistry. IB: 38 (HL 6,6,6), including HL6 in Chemistry and HL6 in one of the following subjects: Biology Computer Science Economics Geography Mathematics Physics.

About this course

MChem (Honours) in Chemistry with Medicinal Chemistry, a chemistry degree situated at the intersection of chemistry with biology and medicine. The course includes a placement year with industrial partners such as AstraZeneca, GlaxoSmithKline and Novartis, and is accredited by the Royal Society of Chemistry. The first year covers foundational principles through modules such as Inorganic and Physical Chemistry 1, Introductory Inorganic and Physical Chemistry, and Organic and Biological Chemistry 1. The second year progresses with Inorganic Chemistry 2, Organic Chemistry 2, and Physical Chemistry 2. The third year offers optional study in Carbohydrate and Nucleic Acid Chemistry, Mechanism in Organic Chemistry, Organometallic Chemistry, Quantitative Aspects of Medicinal Chemistry, and Synthetic Methodology. The fourth year consists of industrial placement opportunities with organisations including BP, DSM, and Roche. The fifth year concludes the programme with advanced study in modules such as Asymmetric Synthesis, Chemical Biology, Molecular Recognition, Natural Products, Biosynthesis and Enzyme Co-factors, and Reactive Intermediates.

Modules

  • Inorganic and Physical Chemistry 1
  • Introductory Inorganic and Physical Chemistry
  • Organic and Biological Chemistry 1
  • Inorganic Chemistry 2
  • Organic Chemistry 2
  • Organic Chemistry 2 (French)
  • Physical Chemistry 2
  • Carbohydrate and Nucleic Acid Chemistry
  • Mechanism in Organic Chemistry
  • Organometallic Chemistry
  • Quantitative Aspects of Medicinal Chemistry
  • Synthetic Methodology
  • AstraZeneca (UK)
  • BP (UK)
  • DSM (Amsterdam, Netherlands)
  • GlaxoSmithKline (UK)
  • Helleday Laboratories (Stockholm, Sweden)
  • Novartis (Basel, Switzerland)
  • Proctor and Gamble (UK)
  • Roche (Basel, Switzerland)
  • Syngenta (UK)
  • Asymmetric Synthesis
  • Chemical Biology
  • Molecular Recognition
  • Natural Products, Biosynthesis and Enzyme Co-factors
  • Reactive Intermediates